Product-by-process claims: a Mexican approach

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Product-by-process claims: a Mexican approach

Sponsored by

olivares-400px.jpg
idea-5060233.jpg

Erika Rocío Santillán of Olivares explains the legal position in Mexico with regard to the protection of inventions through the identification of a novel technical step in the manufacturing process

There are certain inventions in which it is impossible to define a claimed product other than in terms of a manufacturing process. The claims protecting these inventions are known as product-by-process claims.

In other words, these products are defined by a manufacturing process which includes a technical step that confers technical characteristics to the product, which in the same way provides novelty and inventive step to the matter sought to be protected.

Product-by-process claims have the following structure: "Product X characterised by A, B, C..., which is prepared/obtained/obtainable by process Y.”

Mexican practice

In Mexico, product-by-process claims are allowed in practice. The country’s previous Industrial Property Law, which applies to all patent applications filed in Mexico before November 5 2020, states in its Article 45, Section I that the following can be protected: "The claims of a specific product and those related to processes especially conceived for its manufacture or use [emphasis added].”

Likewise, the current Federal Industrial Property Protection Law, which entered into force on November 5 2020, mentions in its Article 55 that "if the subject matter of the patent is a process, the patent confers the right to prevent other persons from using that process and from using, selling, offering for sale or importing the product obtained directly from that process, without their consent [emphasis added].”

Product-by-process claims usually confuse inventors and applicants. Thus, when a product is defined by its manufacturing method, it is relevant to review whether the product obtained is identical to other products that are already known, which will help us not to lose sight of the novelty of the product itself.

Onus on the applicant

It is a reality in several jurisdictions that when a product-by-process-type invention is sought to be protected, it is the applicant's responsibility to provide evidence that the parameters of the process give rise to the claimed product. This is achieved by demonstrating the clear differences in the technical characteristics (properties) of the products.

Finally, it should be noted that a product is not patentable if it is not new, even if the products are manufactured by different processes.

Even for a new product, if the process can be used to manufacture a different product, the manufacturing process and the product produced by the process would be reviewed as two different inventions and would be subject to restrictions.

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article